High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy
Launched by HAUKELAND UNIVERSITY HOSPITAL · Jan 16, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how different power settings on a special laser affect the treatment of kidney stones. Specifically, it compares the time it takes to perform a procedure called ureteroscopic lithotripsy using low power (4-6 watts) versus high power (16-18 watts) settings. The goal is to determine if one setting is more effective than the other in removing stones, which are between 8-25 mm in size, while also looking at potential complications during and after the procedure.
To be eligible for this study, participants must be at least 18 years old and scheduled to undergo this laser treatment at Haukeland University Hospital in Norway. Those with other medical issues, such as additional stones, infections, or untreated cancer in the urinary tract, cannot participate. If you join the study, you'll receive the procedure under general anesthesia and will have a follow-up appointment three months later to check if the stones have been successfully removed. This trial is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital
- Exclusion Criteria:
- • Concomitant ureteral stone
- • Urinary diversion
- • Active infection
- • Untreated cancer in the upper urinary tract
About Haukeland University Hospital
Haukeland University Hospital, located in Bergen, Norway, is a leading academic medical center renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge clinical studies that aim to advance healthcare outcomes. With a multidisciplinary team of healthcare professionals and researchers, Haukeland University Hospital fosters collaboration and knowledge exchange, ensuring that trials are conducted with the highest standards of ethics, safety, and scientific rigor. Its strategic focus on translational research enhances the bridge between laboratory discoveries and real-world applications, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, Vestland, Norway
Patients applied
Trial Officials
Øyvind Ulvik, Assoc Prof
Principal Investigator
Haukeland University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials